Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1998 Apr;88(4):590–596. doi: 10.2105/ajph.88.4.590

The protective effect of condoms and nonoxynol-9 against HIV infection.

K M Wittkowski 1, E Susser 1, K Dietz 1
PMCID: PMC1508428  PMID: 9551000

Abstract

OBJECTIVES: Whether or not spermicides can reduce the risk of human immunodeficiency virus (HIV) transmission remains an important question for the control of heterosexual HIV transmission. The authors provide estimates from a reanalysis of one of the few observational studies on the efficacy of condoms and spermicides, used separately and together, per vaginal contact. METHODS: In this reanalysis, three different models were used to assess the efficacy of spermicides and condoms: linear (Pearl index), exponential (maximum likelihood), and monotonic (marginal likelihood). RESULTS: Reported use of barrier methods among 27,432 contacts was as follows: condoms plus nonoxynol-9, 39%; condoms alone, 25%; nonoxynol-9 alone, 24%; and unprotected, 11%. Under all three models, the results indicate a strong protective effect for spermicidal suppositories. The Pearl index indicated that spermicide alone is apparently efficacious, but the efficacy per contact cannot be quantified with this approach. Maximum likelihood estimates for the efficacy of nonoxynol-9 alone and condoms (with or without nonoxynol-9) were 100% (95% confidence interval [CI95] = 43%, 100%) and 92% (95% CI95 = 79%, 100%), respectively. CONCLUSIONS: The data from this observational study suggest that spermicides may be efficacious in reducing the risk of HIV transmission.

Full text

PDF
590

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albert A. E., Warner D. L., Hatcher R. A., Trussell J., Bennett C. Condom use among female commercial sex workers in Nevada's legal brothels. Am J Public Health. 1995 Nov;85(11):1514–1520. doi: 10.2105/ajph.85.11.1514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown J. E., Ayowa O. B., Brown R. C. Dry and tight: sexual practices and potential AIDS risk in Zaire. Soc Sci Med. 1993 Oct;37(8):989–994. doi: 10.1016/0277-9536(93)90433-5. [DOI] [PubMed] [Google Scholar]
  3. Brown R. C., Brown J. E., Ayowa O. B. The use and physical effects of intravaginal substances in Zairian women. Sex Transm Dis. 1993 Mar-Apr;20(2):96–99. doi: 10.1097/00007435-199303000-00007. [DOI] [PubMed] [Google Scholar]
  4. Civic D., Wilson D. Dry sex in Zimbabwe and implications for condom use. Soc Sci Med. 1996 Jan;42(1):91–98. doi: 10.1016/0277-9536(95)00081-x. [DOI] [PubMed] [Google Scholar]
  5. Elias C., Heise L. L. Nonoxynol-9: the need for policy in the face of uncertainty. AIDS. 1995 Mar;9(3):311–312. [PubMed] [Google Scholar]
  6. Feldblum P. J., Weir S. S. The protective effect of nonoxynol-9 against HIV infection. Am J Public Health. 1994 Jun;84(6):1032–1034. doi: 10.2105/ajph.84.6.1032-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hicks D. R., Martin L. S., Getchell J. P., Heath J. L., Francis D. P., McDougal J. S., Curran J. W., Voeller B. Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet. 1985 Dec 21;2(8469-70):1422–1423. doi: 10.1016/s0140-6736(85)92584-x. [DOI] [PubMed] [Google Scholar]
  8. Hira S. K., Feldblum P. J., Kamanga J., Mukelabai G., Weir S. S., Thomas J. C. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia. Int J STD AIDS. 1997 Apr;8(4):243–250. doi: 10.1258/0956462971919994. [DOI] [PubMed] [Google Scholar]
  9. Hira S. K., Nkowane B. M., Kamanga J., Wadhawan D., Kavindele D., Macuacua R., Mpoko G., Malek M., Cruess D. F., Perine P. L. Epidemiology of human immunodeficiency virus in families in Lusaka, Zambia. J Acquir Immune Defic Syndr. 1990;3(1):83–86. [PubMed] [Google Scholar]
  10. Kreiss J., Ngugi E., Holmes K., Ndinya-Achola J., Waiyaki P., Roberts P. L., Ruminjo I., Sajabi R., Kimata J., Fleming T. R. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA. 1992 Jul 22;268(4):477–482. [PubMed] [Google Scholar]
  11. Louv W. C., Austin H., Alexander W. J., Stagno S., Cheeks J. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. J Infect Dis. 1988 Sep;158(3):518–523. doi: 10.1093/infdis/158.3.518. [DOI] [PubMed] [Google Scholar]
  12. Polsky B., Baron P. A., Gold J. W., Smith J. L., Jensen R. H., Armstrong D. In vitro inactivation of HIV-1 by contraceptive sponge containing nonoxynol-9. Lancet. 1988 Jun 25;1(8600):1456–1456. doi: 10.1016/s0140-6736(88)92261-1. [DOI] [PubMed] [Google Scholar]
  13. Potts M. The urgent need for a vaginal microbicide in the prevention of HIV transmission. Am J Public Health. 1994 Jun;84(6):890–891. doi: 10.2105/ajph.84.6.890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rosenberg M. J., Waugh M. S. Latex condom breakage and slippage in a controlled clinical trial. Contraception. 1997 Jul;56(1):17–21. doi: 10.1016/s0010-7824(97)00069-3. [DOI] [PubMed] [Google Scholar]
  15. Runganga A. O., Kasule J. The vaginal use of herbs/substances: an HIV transmission facilitatory factor? AIDS Care. 1995;7(5):639–645. doi: 10.1080/09540129550126281. [DOI] [PubMed] [Google Scholar]
  16. Sandala L., Lurie P., Sunkutu M. R., Chani E. M., Hudes E. S., Hearst N. 'Dry sex' and HIV infection among women attending a sexually transmitted diseases clinic in Lusaka, Zambia. AIDS. 1995 Jul;9 (Suppl 1):S61–S68. [PubMed] [Google Scholar]
  17. Stein Z. A. HIV prevention: the need for methods women can use. Am J Public Health. 1990 Apr;80(4):460–462. doi: 10.2105/ajph.80.4.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Susser E., Desvarieux M., Wittkowski K. M. Reporting sexual risk behavior for HIV: a practical risk index and a method for improving risk indices. Am J Public Health. 1998 Apr;88(4):671–674. doi: 10.2105/ajph.88.4.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Trap R., Trap B., Petersen C. S. Evaluation of the amount of nonoxynol available in condoms for the inhibition of HIV using a method based on HPLC. Int J STD AIDS. 1990 Sep;1(5):346–348. doi: 10.1177/095646249000100509. [DOI] [PubMed] [Google Scholar]
  20. Trussell J., Kost K. Contraceptive failure in the United States: a critical review of the literature. Stud Fam Plann. 1987 Sep-Oct;18(5):237–283. [PubMed] [Google Scholar]
  21. Weir S. S., Feldblum P. J., Zekeng L., Roddy R. E. The use of nonoxynol-9 for protection against cervical gonorrhea. Am J Public Health. 1994 Jun;84(6):910–914. doi: 10.2105/ajph.84.6.910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wittkowski K. M. Pravention der HIV-Infektion. I. Die Abschatzung der Effektivitat von Barriere-Methoden zur HIV-Prophylaxe. AIDS Forsch. 1989 Jan;4(1):3–8. [PubMed] [Google Scholar]
  23. Wittkowski K. M. Preventing the heterosexual spread of AIDS: what is the best advice if compliance is taken into account? AIDS. 1989 Mar;3(3):143–145. [PubMed] [Google Scholar]
  24. Wittkowski K. M. The efficacy of nonoxynol-9 from an in vivo point of view. AIDS. 1997 Mar;11(3):392–394. [PubMed] [Google Scholar]
  25. Wittkowski K. M. The potential of nonoxynol-9 for the prevention of HIV infection reconsidered. AIDS. 1995 Mar;9(3):310–311. [PubMed] [Google Scholar]
  26. Zekeng L., Feldblum P. J., Oliver R. M., Kaptue L. Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS. 1993 May;7(5):725–731. doi: 10.1097/00002030-199305000-00018. [DOI] [PubMed] [Google Scholar]
  27. de Graaf R., Vanwesenbeeck I., van Zessen G., Straver C. J., Visser J. H. The effectiveness of condom use in heterosexual prostitution in The Netherlands. AIDS. 1993 Feb;7(2):265–269. doi: 10.1097/00002030-199302000-00016. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES